This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedlander, P.
Right arrow Articles by Oren, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedlander, P.
Right arrow Articles by Oren, M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Sep 1996, 4961-4971, Vol 16, No. 9
Copyright © 1996, American Society for Microbiology

A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis

P Friedlander, Y Haupt, C Prives and M Oren
Department of Biological Sciences, Columbia University, New York 10027, USA.

Human wild-type (wt) p53 can induce apoptosis in transiently transfected H1299 cells maintained at 37 degrees C, whereas tumor- derived mutant forms of p53 (with the mutation Ala-143, His-175, or Trp- 248) fail to do so. At 37 degrees C, p53 with a mutation to Ala at amino acid 143 (p53Ala143) was transcriptionally inactive. However, at 32 degrees C, p53Ala143 strongly activated transcription from several physiologically relevant p53-responsive promoters, to extents similar or greater than that of wt p53. Unexpectedly, p53Ala143 was defective in inducing apoptosis in H1299 cells at 32 degrees C. Concomitantly with the loss of apoptotic activity, p53Ala143 was found to be deficient in its ability to activate transcription from the p53- responsive portions of the Bax and insulin-like growth factor-binding protein 3 gene promoters. It is proposed that there may exist distinct classes of p53-responsive promoters, whose ability to be activated by p53 can be regulated differentially. Such differential regulation may have functional consequences for the effects of p53 on cell fate.


This article has been cited by other articles:

  • Nyman, U., Vlachos, P., Cascante, A., Hermanson, O., Zhivotovsky, B., Joseph, B. (2009). Protein Kinase C-Dependent Phosphorylation Regulates the Cell Cycle-Inhibitory Function of the p73 Carboxy Terminus Transactivation Domain. Mol. Cell. Biol. 29: 1814-1825 [Abstract] [Full Text]  
  • Rani, R., Li, J., Pang, Q. (2008). Differential p53 Engagement in Response to Oxidative and Oncogenic Stresses in Fanconi Anemia Mice. Cancer Res. 68: 9693-9702 [Abstract] [Full Text]  
  • Vousden, K. H. (2006). Outcomes of p53 activation - spoilt for choice. J. Cell Sci. 119: 5015-5020 [Abstract] [Full Text]  
  • Tidow, H., Veprintsev, D. B., Freund, S. M. V., Fersht, A. R. (2006). Effects of Oncogenic Mutations and DNA Response Elements on the Binding of p53 to p53-binding Protein 2 (53BP2). J. Biol. Chem. 281: 32526-32533 [Abstract] [Full Text]  
  • Lopez-Soto, A., Quinones-Lombrana, A., Lopez-Arbesu, R., Lopez-Larrea, C., Gonzalez, S. (2006). Transcriptional Regulation of ULBP1, a Human Ligand of the NKG2D Receptor. J. Biol. Chem. 281: 30419-30430 [Abstract] [Full Text]  
  • Lacroix, M., Toillon, R.-A., Leclercq, G. (2006). p53 and breast cancer, an update.. Endocr Relat Cancer 13: 293-325 [Abstract] [Full Text]  
  • Panduri, V., Surapureddi, S., Soberanes, S., Weitzman, S. A., Chandel, N., Kamp, D. W. (2006). P53 Mediates Amosite Asbestos-Induced Alveolar Epithelial Cell Mitochondria-Regulated Apoptosis. Am. J. Respir. Cell Mol. Bio. 34: 443-452 [Abstract] [Full Text]  
  • Warburton, H. E., Brady, M., Vlatkovic, N., Linehan, W. M., Parsons, K., Boyd, M. T. (2005). p53 Regulation and Function in Renal Cell Carcinoma. Cancer Res. 65: 6498-6503 [Abstract] [Full Text]  
  • Grimberg, A., Coleman, C. M., Burns, T. F., Himelstein, B. P., Koch, C. J., Cohen, P., El-Deiry, W. S. (2005). p53-Dependent and p53-Independent Induction of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid Damage and Hypoxia. J. Clin. Endocrinol. Metab. 90: 3568-3574 [Abstract] [Full Text]  
  • Li, Y., Mao, Y., Brandt-Rauf, P. W., Williams, A. C., Fine, R. L. (2005). Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway. Molecular Cancer Therapeutics 4: 901-909 [Abstract] [Full Text]  
  • Harms, K. L., Chen, X. (2005). The C Terminus of p53 Family Proteins Is a Cell Fate Determinant. Mol. Cell. Biol. 25: 2014-2030 [Abstract] [Full Text]  
  • Lo, P.-K., Huang, S.-Z., Chen, H.-C., Wang, F.-F. (2004). The Prosurvival Activity of p53 Protects Cells from UV-Induced Apoptosis by Inhibiting c-Jun NH2-terminal Kinase Activity and Mitochondrial Death Signaling. Cancer Res. 64: 8736-8745 [Abstract] [Full Text]  
  • Kwun, H. J., Jang, K. L. (2004). Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res 32: 2202-2213 [Abstract] [Full Text]  
  • Banerjee, S., Kumar, B. R. P., Kundu, T. K. (2004). General Transcriptional Coactivator PC4 Activates p53 Function. Mol. Cell. Biol. 24: 2052-2062 [Abstract] [Full Text]  
  • Reczek, E. E., Flores, E. R., Tsay, A. S., Attardi, L. D., Jacks, T. (2003). Multiple Response Elements and Differential p53 Binding Control Perp Expression During Apoptosis. Mol Cancer Res 1: 1048-1057 [Abstract] [Full Text]  
  • de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., Jochemsen, A. G. (2003). Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2. J. Biol. Chem. 278: 38315-38324 [Abstract] [Full Text]  
  • Ruiz-Ruiz, C., Robledo, G., Cano, E., Redondo, J. M., Lopez-Rivas, A. (2003). Characterization of p53-mediated Up-regulation of CD95 Gene Expression upon Genotoxic Treatment in Human Breast Tumor Cells. J. Biol. Chem. 278: 31667-31675 [Abstract] [Full Text]  
  • Li, Y., Raffo, A. J., Drew, L., Mao, Y., Tran, A., Petrylak, D. P., Fine, R. L. (2003). Fas-Mediated Apoptosis Is Dependent on Wild-Type p53 Status in Human Cancer Cells Expressing a Temperature-Sensitive p53 Mutant Alanine-143. Cancer Res. 63: 1527-1533 [Abstract] [Full Text]  
  • Inga, A., Storici, F., Darden, T. A., Resnick, M. A. (2002). Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence. Mol. Cell. Biol. 22: 8612-8625 [Abstract] [Full Text]  
  • Sanchez-Carbayo, M., Socci, N. D., Charytonowicz, E., Lu, M., Prystowsky, M., Childs, G., Cordon-Cardo, C. (2002). Molecular Profiling of Bladder Cancer Using cDNA Microarrays: Defining Histogenesis and Biological Phenotypes. Cancer Res. 62: 6973-6980 [Abstract] [Full Text]  
  • Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3. Mol. Cell. Biol. 22: 5801-5812 [Abstract] [Full Text]  
  • Ma, P., Magut, M., Chen, X., Chen, C.-Y. (2002). p53 Is Necessary for the Apoptotic Response Mediated by a Transient Increase of Ras Activity. Mol. Cell. Biol. 22: 2928-2938 [Abstract] [Full Text]  
  • Fulci, G., Ishii, N., Maurici, D., Gernert, K. M., Hainaut, P., Kaur, B., Van Meir, E. G. (2002). Initiation of Human Astrocytoma by Clonal Evolution of Cells with Progressive Loss of p53 Functions in a Patient with a 283H TP53 Germ-line Mutation: Evidence for a Precursor Lesion. Cancer Res. 62: 2897-2905 [Abstract] [Full Text]  
  • Stros, M., Ozaki, T., Bacikova, A., Kageyama, H., Nakagawara, A. (2002). HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter. J. Biol. Chem. 277: 7157-7164 [Abstract] [Full Text]  
  • Dubrez, L., Coll, J.-L., Hurbin, A., Solary, E., Favrot, M.-C. (2001). Caffeine Sensitizes Human H358 Cell Line to p53-mediated Apoptosis by Inducing Mitochondrial Translocation and Conformational Change of BAX Protein. J. Biol. Chem. 276: 38980-38987 [Abstract] [Full Text]  
  • Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., Cat, I., Stratakis, C. A., Sandrini, R. (2001). An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. USA 98: 9330-9335 [Abstract] [Full Text]  
  • Liu, Y., Kulesz-Martin, M. (2001). p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 22: 851-860 [Abstract] [Full Text]  
  • Cerrato, J. A., Yung, W.K. A., Liu, T.-J. (2001). Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis. Neuro Oncol Duke 3: 113-122 [Abstract]  
  • Kovvali, G. K., Mehta, B., Epstein, C. B., Lutzker, S. G. (2001). Identification of partial loss of function p53 gene mutations utilizing a yeast-based functional assay. Nucleic Acids Res 29: e28-e28 [Abstract] [Full Text]  
  • Eichhorst, S. T., Müerköster, S., Weigand, M. A., Krammer, P. H. (2001). The Chemotherapeutic Drug 5-Fluorouracil Induces Apoptosis in Mouse Thymocytes in Vivo via Activation of the CD95(APO-1/Fas) System. Cancer Res. 61: 243-248 [Abstract] [Full Text]  
  • Chylicki, K., Ehinger, M., Svedberg, H., Gullberg, U. (2000). Characterization of the Molecular Mechanisms for p53-mediated Differentiation. Cell Growth Differ. 11: 561-571 [Abstract] [Full Text]  
  • Ruiz-Ruiz, C., Muñoz-Pinedo, C., López-Rivas, A. (2000). Interferon-{{gamma}} Treatment Elevates Caspase-8 Expression and Sensitizes Human Breast Tumor Cells to a Death Receptor-induced Mitochondria-operated Apoptotic Program. Cancer Res. 60: 5673-5680 [Abstract] [Full Text]  
  • BLAGOSKLONNY, M. V. (2000). p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J. 14: 1901-1907 [Abstract] [Full Text]  
  • Zhu, J., Chen, X. (2000). MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M. Mol. Cell. Biol. 20: 5602-5618 [Abstract] [Full Text]  
  • Hegi, M. E., Klein, M. A., Ruedi, D., Chene, P., Hamou, M.-F., Aguzzi, A. (2000). p53 Transdominance But No Gain of Function in Mouse Brain Tumor Model. Cancer Res. 60: 3019-3024 [Abstract] [Full Text]  
  • Robert, V., Michel, P., Flaman, J. M., Chiron, A., Martin, C., Charbonnier, F., Paillot, B., Frebourg, T. (2000). High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 21: 563-565 [Abstract] [Full Text]  
  • Scharnhorst, V., Dekker, P., van der Eb, A. J., Jochemsen, A. G. (2000). Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions. J. Biol. Chem. 275: 10202-10211 [Abstract] [Full Text]  
  • Lowe, S. W., Lin, A. W. (2000). Apoptosis in cancer. Carcinogenesis 21: 485-495 [Abstract] [Full Text]  
  • O'Reilly, M. A., Staversky, R. J., Watkins, R. H., Maniscalco, W. M., Keng, P. C. (2000). p53-independent induction of GADD45 and GADD153 in mouse lungs exposed to hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L552-L559 [Abstract] [Full Text]  
  • Munsch, D., Watanabe-Fukunaga, R., Bourdon, J.-C., Nagata, S., May, E., Yonish-Rouach, E., Reisdorf, P. (2000). Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis. J. Biol. Chem. 275: 3867-3872 [Abstract] [Full Text]  
  • Aurelio, O. N., Kong, X.-T., Gupta, S., Stanbridge, E. J. (2000). p53 Mutants Have Selective Dominant-Negative Effects on Apoptosis but Not Growth Arrest in Human Cancer Cell Lines. Mol. Cell. Biol. 20: 770-778 [Abstract] [Full Text]  
  • Ozaki, T., Naka, M., Takada, N., Tada, M., Sakiyama, S., Nakagawara, A. (1999). Deletion of the COOH-Terminal Region of p73{{alpha}} Enhances Both Its Transactivation Function and DNA-binding Activity but Inhibits Induction of Apoptosis in Mammalian Cells. Cancer Res. 59: 5902-5907 [Abstract] [Full Text]  
  • Thornborrow, E. C., Manfredi, J. J. (1999). One Mechanism for Cell Type-specific Regulation of the bax Promoter by the Tumor Suppressor p53 Is Dictated by the p53 Response Element. J. Biol. Chem. 274: 33747-33756 [Abstract] [Full Text]  
  • Wong, K.-B., DeDecker, B. S., Freund, S. M. V., Proctor, M. R., Bycroft, M., Fersht, A. R. (1999). Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc. Natl. Acad. Sci. USA 96: 8438-8442 [Abstract] [Full Text]  
  • Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., Rosenberg, N. (1999). p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells. Mol. Cell. Biol. 19: 4825-4831 [Abstract] [Full Text]  
  • Steegenga, W. T., Shvarts, A., Riteco, N., Bos, J. L., Jochemsen, A. G. (1999). Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins. Mol. Cell. Biol. 19: 3885-3894 [Abstract] [Full Text]  
  • Moller, M. B., Gerdes, A.-M., Skjodt, K., Mortensen, L. S., Pedersen, N. T. (1999). Disrupted p53 Function as Predictor of Treatment Failure and Poor Prognosis in B- and T-Cell Non-Hodgkin's Lymphoma. Clin. Cancer Res. 5: 1085-1091 [Abstract] [Full Text]  
  • Sionov, R. V., Moallem, E., Berger, M., Kazaz, A., Gerlitz, O., Ben-Neriah, Y., Oren, M., Haupt, Y. (1999). c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53. J. Biol. Chem. 274: 8371-8374 [Abstract] [Full Text]  
  • Ashcroft, M., Kubbutat, M. H. G., Vousden, K. H. (1999). Regulation of p53 Function and Stability by Phosphorylation. Mol. Cell. Biol. 19: 1751-1758 [Abstract] [Full Text]  
  • Di Como, C. J., Gaiddon, C., Prives, C. (1999). p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells. Mol. Cell. Biol. 19: 1438-1449 [Abstract] [Full Text]  
  • Shu, H.-K. G., Kim, M. M., Chen, P., Furman, F., Julin, C. M., Israel, M. A. (1998). The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21BAX expression. Proc. Natl. Acad. Sci. USA 95: 14453-14458 [Abstract] [Full Text]  
  • Nalca, A., Rangnekar, V. M. (1998). The G1-phase Growth-arresting Action of Interleukin-1 Is Independent of p53 and p21/WAF1 Function. J. Biol. Chem. 273: 30517-30523 [Abstract] [Full Text]  
  • Tang, H.-y., Zhao, K., Pizzolato, J. F., Fonarev, M., Langer, J. C., Manfredi, J. J. (1998). Constitutive Expression of the Cyclin-dependent Kinase Inhibitor p21 Is Transcriptionally Regulated by the Tumor Suppressor Protein p53. J. Biol. Chem. 273: 29156-29163 [Abstract] [Full Text]  
  • Wilson, J. W., Pritchard, D. M., Hickman, J. A., Potten, C. S. (1998). Radiation-Induced p53 and p21WAF-1/CIP1 Expression in the Murine Intestinal Epithelium : Apoptosis and Cell Cycle Arrest. Am. J. Pathol. 153: 899-909 [Abstract] [Full Text]  
  • Evan, G., Littlewood, T. (1998). A Matter of Life and Cell Death. Science 281: 1317-1322 [Abstract] [Full Text]  
  • Resnick-Silverman, L., St. Clair, S., Maurer, M., Zhao, K., Manfredi, J. J. (1998). Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev. 12: 2102-2107 [Abstract] [Full Text]  
  • Ryan, K. M., Vousden, K. H. (1998). Characterization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle Arrest. Mol. Cell. Biol. 18: 3692-3698 [Abstract] [Full Text]  
  • Haunstetter, A., Izumo, S. (1998). Apoptosis : Basic Mechanisms and Implications for Cardiovascular Disease. Circ. Res. 82: 1111-1129 [Full Text]  
  • Xiang, H., Kinoshita, Y., Knudson, C. M., Korsmeyer, S. J., Schwartzkroin, P. A., Morrison, R. S. (1998). Bax Involvement in p53-Mediated Neuronal Cell Death. J. Neurosci. 18: 1363-1373 [Abstract] [Full Text]  
  • Jayaraman, L., Moorthy, N. C., Murthy, K. G.K., Manley, J. L., Bustin, M., Prives, C. (1998). High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 12: 462-472 [Abstract] [Full Text]  
  • O'Reilly, M. A., Staversky, R. J., Stripp, B. R., Finkelstein, J. N. (1998). Exposure to Hyperoxia Induces p53 Expression in Mouse Lung Epithelium. Am. J. Respir. Cell Mol. Bio. 18: 43-50 [Abstract] [Full Text]  
  • Nair, P., Muthukkumar, S., Sells, S. F., Han, S.-S., Sukhatme, V. P., Rangnekar, V. M. (1997). Early Growth Response-1-dependent Apoptosis Is Mediated by p53. J. Biol. Chem. 272: 20131-20138 [Abstract] [Full Text]  
  • Rechler, M. M. (1997). Editorial: Growth Inhibition by Insulin-Like Growth Factor (IGF) Binding Protein-3--What's IGF Got To Do with It?. Endocrinology 138: 2645-2647 [Full Text]  
  • Rajah, R., Valentinis, B., Cohen, P. (1997). Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-beta 1 on Programmed Cell Death through a p53- and IGF-independent Mechanism. J. Biol. Chem. 272: 12181-12188 [Abstract] [Full Text]  
  • Jayaraman, L, Murthy, K G, Zhu, C, Curran, T, Xanthoudakis, S, Prives, C (1997). Identification of redox/repair protein Ref-1 as a potent activator of p53.. Genes Dev. 11: 558-570 [Abstract]  
  • Yuan, Z.-M., Huang, Y., Ishiko, T., Kharbanda, S., Weichselbaum, R., Kufe, D. (1997). Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94: 1437-1440 [Abstract] [Full Text]  
  • Chen, X, Ko, L J, Jayaraman, L, Prives, C (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.. Genes Dev. 10: 2438-2451 [Abstract]  
  • Stad, R., Ramos, Y. F. M., Little, N., Grivell, S., Attema, J., van der Eb, A. J., Jochemsen, A. G. (2000). Hdmx Stabilizes Mdm2 and p53. J. Biol. Chem. 275: 28039-28044 [Abstract] [Full Text]  
  • Berger, M., Vogt Sionov, R., Levine, A. J., Haupt, Y. (2001). A Role for the Polyproline Domain of p53 in Its Regulation by Mdm2. J. Biol. Chem. 276: 3785-3790 [Abstract] [Full Text]  
  • Thornborrow, E. C., Manfredi, J. J. (2001). The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter. J. Biol. Chem. 276: 15598-15608 [Abstract] [Full Text]  
  • Brosh, R. M. Jr., Karmakar, P., Sommers, J. A., Yang, Q., Wang, X. W., Spillare, E. A., Harris, C. C., Bohr, V. A. (2001). p53 Modulates the Exonuclease Activity of Werner Syndrome Protein. J. Biol. Chem. 276: 35093-35102 [Abstract] [Full Text]  
  • Kong, X.-T., Gao, H., Stanbridge, E. J. (2001). Mechanisms of Differential Activation of Target Gene Promoters by p53 Hinge Domain Mutants with Impaired Apoptotic Function. J. Biol. Chem. 276: 32990-33000 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»